DE69536065D1 - Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung - Google Patents

Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung

Info

Publication number
DE69536065D1
DE69536065D1 DE69536065T DE69536065T DE69536065D1 DE 69536065 D1 DE69536065 D1 DE 69536065D1 DE 69536065 T DE69536065 T DE 69536065T DE 69536065 T DE69536065 T DE 69536065T DE 69536065 D1 DE69536065 D1 DE 69536065D1
Authority
DE
Germany
Prior art keywords
methods
therapeutic use
signal oligopeptides
oligopeptides
hydrophilic signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69536065T
Other languages
English (en)
Inventor
Matthias Dr Med Rath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69536065D1 publication Critical patent/DE69536065D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE69536065T 1994-01-14 1995-01-12 Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung Expired - Lifetime DE69536065D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18224894A 1994-01-14 1994-01-14

Publications (1)

Publication Number Publication Date
DE69536065D1 true DE69536065D1 (de) 2010-05-27

Family

ID=22667644

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69536065T Expired - Lifetime DE69536065D1 (de) 1994-01-14 1995-01-12 Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung
DE69534077T Expired - Lifetime DE69534077T2 (de) 1994-01-14 1995-01-12 Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69534077T Expired - Lifetime DE69534077T2 (de) 1994-01-14 1995-01-12 Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden

Country Status (8)

Country Link
EP (2) EP0744027B1 (de)
AT (2) ATE291230T1 (de)
AU (1) AU1681095A (de)
DE (2) DE69536065D1 (de)
DK (1) DK0744027T3 (de)
ES (2) ES2344643T3 (de)
PT (1) PT744027E (de)
WO (1) WO1995019568A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168456T3 (es) * 1995-01-16 2002-06-16 North Sydney Area Health Serv Peptidos que afectan a los linfocitos t.
GB9615533D0 (en) * 1996-07-24 1996-09-04 Peptide Therapeutics Ltd Diagnostic test for herpes simplex virus type-2
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
US6902888B1 (en) 1999-05-21 2005-06-07 Myriad Genetics, Inc. Diabetes gene
WO2000071751A1 (en) * 1999-05-21 2000-11-30 Myriad Genetics, Inc. Diabetes gene
AU2003211501A1 (en) * 2002-02-08 2003-09-02 Nakoshi, Hideo Peptides
WO2009008888A1 (en) * 2007-07-10 2009-01-15 Matthias Rath African swine virus polypeptides as vaccines and its therapeutic use thereof
GB201214493D0 (en) * 2012-08-14 2012-09-26 Univ Ulster Therapies
GB2543550A (en) * 2015-10-21 2017-04-26 Hox Therapeutics Ltd Peptides
EP3624841A4 (de) 2017-06-15 2021-01-27 Cancer Advances, Inc., Zusammensetzungen und verfahren zur induzierung humoraler und zellulärer immunitäten gegen tumore und krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
JP2716503B2 (ja) * 1987-12-23 1998-02-18 ジ・アップジョン・カンパニー ヒト呼吸系シンシチウムウイルスの糖蛋白類の免疫原性セグメントを含有するキメラ糖蛋白類
US5169628A (en) * 1988-04-22 1992-12-08 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3

Also Published As

Publication number Publication date
EP0744027A1 (de) 1996-11-27
ATE291230T1 (de) 2005-04-15
EP1520859B1 (de) 2010-04-14
EP1520859A2 (de) 2005-04-06
EP1520859B9 (de) 2010-12-29
EP0744027A4 (de) 2000-09-06
EP0744027B1 (de) 2005-03-16
WO1995019568A1 (en) 1995-07-20
PT744027E (pt) 2005-05-31
AU1681095A (en) 1995-08-01
DE69534077D1 (de) 2005-04-21
DK0744027T3 (da) 2005-06-13
EP1520859A3 (de) 2008-08-20
ES2344643T3 (es) 2010-09-02
DE69534077T2 (de) 2005-08-11
ATE464315T1 (de) 2010-04-15
ES2236703T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
DE3877897D1 (de) Verfahren und vorrichtung zur erzeugung von verbesserten russen und erhaltenes produkt.
DE68914466D1 (de) Verfahren und vorrichtung zur verwendung von schwingungen am menschlichen körper.
ATE111701T1 (de) Verfahren und vorrichtung zur herstellung von borstenwaren.
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
FR10C0016I2 (fr) Procedes et compositions s'appliquant au traitement de la glomerulonephrite
DE68919923D1 (de) Verfahren und Vorrichtung zur Authentifizierung.
DE68915233D1 (de) Verfahren und Vorrichtung zur Herstellung von Kontaktlinsen.
DE69502952T2 (de) Vorrichtung zur erzeugung von instruktionen
DE69535054D1 (de) Verfahren zur Ozonerzeugung und Methoden zur Benutzung der Vorrichtung
DE3775037D1 (de) Verfahren und vorrichtung zur herstellung von zierschleifen.
ATE464315T1 (de) Hydrophile signal-oligopeptide und verfahren der therapeutischen anwendung
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69004297D1 (de) Vorrichtung und Verfahren zum Herstellen von Zigaretten.
DE69013880D1 (de) Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
DE69517263D1 (de) Vorrichtung zur Erzeugung von Tonsignalen
DE68924361D1 (de) Mit Ultraschall gebundene Stoffbahn und Verfahren zur Herstellung derselben.
DE58906655D1 (de) Druckaufnehmer und Verfahren zur Kalibrierung von Druckaufnehmern.
ATE235056T1 (de) Verfahren zur diagnose und therapie von plattenepithelkarzinomen
DE3860637D1 (de) Verfahren und vorrichtung zur herstellung von synthesegas.
DE69634116D1 (de) Vorrichtung und verfahren zur herstellung von hochabriebfester kolbenring
DE68917141D1 (de) Vorrichtung und verfahren zur herstellung nichtgewebter textilien.
ATE309371T1 (de) Protein mit dnase-aktivität
DE69014084D1 (de) Verfahren und Vorrichtung zur Herstellung von Borstenbüscheln.
ATE179152T1 (de) Vorrichtung zur oberflächenbehandlung von hohlglaskörpern
DE3750580D1 (de) Vorrichtung und verfahren zur verbesserten wassermassage.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition